Titan Pharma (TTNP) Announces Probuphine Phase 3 Data Presented at ASAM Conference
Tweet Send to a Friend
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced today the presentation of data from the last Phase 3 study of Probuphine®, a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
